We have a number of equity investments in privately held companies that are unconsolidated entities and are recorded in the non-current balance of other assets on the consolidated condensed balance sheets. The following table shows a reconciliation of the changes in all of our investments (in thousands):


	Six Months Ended ‎December 31,
	2019		2018
Equity method investments
Balance at the beginning of the period	$	21,667	$	-
Investments		17,500		25,000
Loss attributable to equity method investments		(13,786)		(3,375)
Carrying value of equity method investments		25,381		21,625

Non-marketable securities
Balance at the beginning of the period	$	30,436	$	41,226
Investments		4,341		2,967
Impairment of investments		(5,419)		(2,959)
Carrying value of non-marketable securities		29,358		41,234

Total investments in unconsolidated entities	$	54,739	$	62,859

Equity investments whereby we have significant influence but not control over the investee, and are not the primary beneficiary of the investee’s activities, are accounted for under the equity method. Under this method, we record our share of gains or losses attributable to equity method investments.

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. We estimate the fair value of our equity investments using Level 3 inputs to assess whether impairment losses shall be recorded.